ArticleJournal of drug issues2023
Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators.
Article in Journal of drug issues, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 22 citations in OpenAlex.
- Perspectives on collaboration between drug courts and MOUD providers: Impact of interagency implementation strategies.Drug and alcohol dependence · 2026Article
- Are Operations Backed by Best Practices in American Problem-Solving Courts?Journal of substance use · 2025Article
- Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.JAMA network open · 2025Article
- The wide-angle lens of implementation science to improve health outcomes in criminal legal settings.Health & justice · 2025Review
- Factors affecting problem-solving court team decisions about medications for opioid use disorder.Journal of substance use and addiction treatment · 2025Article
- Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.JAMA network open · 2024Article
- A National Survey of Problem-Solving Court Staff Perceptions of In-Person versus Virtual Hearings.The journal of the American Academy of Psychiatry and the Law · 2024Article
- Pandemic Procedures: Adapting Problem-Solving Court (PSC) Operations and Treatment Protocols During COVID-19.Journal of drug issues · 2023Article
- Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers.Journal of substance use and addiction treatment · 2023Article
- Viewing Then Doing?: Problem-Solving Court Coordinators' Perceptions of Medications for Opioid Use Disorders from a Nationally Representative Survey in the United States.Substance use & misuse · 2023Article
- Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities-overview and commentary.Addiction science & clinical practice · 2022Review
- Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting.Journal of addiction medicineArticle
- Pharmacist roles enhancing substance use disorder treatment access, continuation, and education in a problem-solving court.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Problem-solving courts (PSCs) are a critical part of a societal effort to mitigate the opioid epidemic's devastating consequences. This paper reports on a national survey of PSCs (N = 42 state-wide court coordinators; N = 849 local court coordinators) and examines the structural factors that could explain the likelihood of a local PSC authorizing medication-assisted treatment (MAT) and MAT utilization. Results of the analyses indicate that MAT availability at the county level was a significant predictor of the likelihood of local courts authorizing MAT. The court's location in a Medicaid expansion state was also a significant predictor of local courts allowing buprenorphine and methadone, but not naltrexone. Problem-solving courts are in the early stages of supporting the use of medications, even when funding is available through Medicaid expansion policies. Adoption and use of treatment innovations like MAT are affected by coordinators' perceptions of MAT as well as structural factors such as the availability of the medications in the community and funding resources. The study has important implications for researchers, policymakers, and practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.